Chongqing Pharscin Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003308
CNY
15.69
-0.39 (-2.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
762.71
680.53
772.84
834.56
872.66
835.05
691.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
762.71
680.53
772.84
834.56
872.66
835.05
691.40
Raw Material Cost
360.60
336.66
332.77
412.29
468.65
320.21
242.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
102.87
103.78
105.79
71.86
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.03
1.01
14.44
18.25
17.23
9.22
1.27
Selling and Distribution Expenses
288.11
244.25
282.40
284.98
257.82
321.34
303.91
Other Expenses
5.14
6.98
4.44
-7.94
-8.45
-8.94
-5.79
Total Expenditure (Excl Depreciation)
700.18
651.75
673.99
738.99
762.95
667.10
562.04
Operating Profit (PBDIT) excl Other Income
62.5
28.799999999999997
98.9
95.60000000000001
109.7
168
129.4
Other Income
30.90
19.08
28.58
29.53
44.48
37.68
32.97
Operating Profit (PBDIT)
179.14
129.58
198.91
191.87
200.97
228.99
182.97
Interest
0.03
1.01
14.44
18.25
17.23
9.22
1.27
Exceptional Items
7.56
3.52
1.57
1.09
1.25
1.95
0.00
Gross Profit (PBDT)
402.11
343.87
440.07
422.27
404.00
514.84
448.49
Depreciation
86.10
81.19
72.65
67.33
47.32
23.74
20.79
Profit Before Tax
100.57
50.89
113.39
107.38
137.67
197.99
160.91
Tax
16.71
10.10
9.84
11.64
17.86
28.25
23.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
76.73
32.70
98.40
91.78
119.19
169.75
137.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
76.73
32.70
98.40
91.78
119.19
169.75
137.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
76.73
32.70
98.40
91.78
119.19
169.75
137.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,660.00
1,617.92
1,610.39
1,183.59
1,099.47
1,070.80
828.91
Earnings per share (EPS)
0.18
0.08
0.24
0.23
0.3
0.42
0.34
Diluted Earnings per share
0.18
0.08
0.24
0.23
0.3
0.42
0.34
Operating Profit Margin (Excl OI)
8.15%
4.31%
12.64%
11.38%
12.51%
20.07%
18.69%
Gross Profit Margin
24.47%
19.41%
24.07%
20.93%
21.2%
26.55%
26.28%
PAT Margin
10.06%
4.8%
12.73%
11.0%
13.66%
20.33%
19.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 12.08% vs -11.94% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 134.56% vs -66.77% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 34.12% vs -35.11% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -100.00% vs -93.06% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Chongqing Pharscin Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
762.71
0
762.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
762.71
0
762.71
Raw Material Cost
360.60
0
360.60
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.03
0
0.03
Selling and Distribution Expenses
288.11
0
288.11
Other Expenses
5.14
0.00
5.14
Total Expenditure (Excl Depreciation)
700.18
0
700.18
Operating Profit (PBDIT) excl Other Income
62.54
0.00
62.54
Other Income
30.90
0
30.90
Operating Profit (PBDIT)
179.14
0
179.14
Interest
0.03
0
0.03
Exceptional Items
7.56
0
7.56
Gross Profit (PBDT)
402.11
0
402.11
Depreciation
86.10
0
86.10
Profit Before Tax
100.57
0
100.57
Tax
16.71
0
16.71
Provisions and contingencies
0
0
0.00
Profit After Tax
76.73
0
76.73
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
76.73
0
76.73
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
76.73
0
76.73
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,660.00
0
1,660.00
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
8.15%
0%
0.00
8.15%
Gross Profit Margin
24.47%
0%
0.00
24.47%
PAT Margin
10.06%
0%
0.00
10.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 76.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.08% vs -11.94% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 7.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 134.56% vs -66.77% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.82 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 34.12% vs -35.11% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.15%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023